Agios Pharmaceuticals AGIO Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agios Pharmaceuticals's change in AR?
- Agios Pharmaceuticals (AGIO) reported change in AR of $5.56M in Q1 2026.
- How has Agios Pharmaceuticals's change in AR changed year-over-year?
- Agios Pharmaceuticals's change in AR increased by 826.1% year-over-year, from -$765K to $5.56M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.